Raptor Pharmaceutical Corp. (NASDAQ:RPTP) announced the appointment of Ashley Gould, J.
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) reported financial results for the first quarter ended March 31, 2015 and provided an update on recent corporate developments.
Raptor Pharmaceutical Corp. (NASDAQ:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people affected by rare and debilitating diseases, today …
Raptor Pharmaceutical Corp. (Nasdaq:RPTP) announced its support of Rare Disease Day on February 28, 2015 with a series of initiatives and events meant to …
In a research note released this morning, Janney Capital analyst Kimberly Lee maintained a Buy rating on Raptor Pharmaceutical (RPTP) with a $17 …